Live long in Andorra and Japan
Latest global survey of life expectancy shows steady increases for most of the world since 2000
The latest issue of The Lancet contains multiple articles on the Global Burden of Disease study, an ongoing, multinational project to measure longevity, health and disease impact around the world. The latest (2010) survey, sponsored by the Bill and Melinda Gates Foundation, finds that overall global life expectancy has increased from 64.2 to 67.5 for men, and from 69.8 to 73.3 for women. The US’ figures are, respectively, 75.9 and 80.5.
Such studies are enormously complex, factoring in age cohorts, fertility, reporting mechanisms and other factors—but even so, it’s an interesting way to look at the combination of lifestyle and healthcare by nation. A considerable portion of the debate over Obamacare for the past few years has focused on disparities in healthcare based on economic status; these data put some of that debate on a worldwide scale.
The longest-lived men today, according to GBD, are in Andorra, where they live to be 79.8; for women, it’s Japan: 85.9. The average for all “Western Europe” (perhaps the closest comparator to the US) is 77.9 for men, 83.2 for women. The far-and-away leader in decline of life expectancy was Haiti, where the latest data put the average for men at 32.5, and for women at 43.6—but the Haitian earthquake is certainly a factor there.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
